ADAG (Adagene Inc.) Stock Market Reviews

crown

search

Read and share opinions on ADAG (Adagene Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ADAG

Adagene Inc.

clarify Biotechnology

bookmark Healthcare

public China

Sell Neutral Buy

Latest News

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
Nov 13, 2025
All You Need to Know About Adagene (ADAG) Rating Upgrade to Buy
Sep 30, 2025
Are Medical Stocks Lagging Adagene (ADAG) This Year?
Sep 25, 2025
Could Access to SAFEbody Technology Shift Exelixis (EXEL) Pipeline Strategy in Oncology?
Sep 18, 2025
Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate
Sep 16, 2025
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Sep 8, 2025
Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
Sep 5, 2025
Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor
Sep 3, 2025
Adagene to Participate in Two Investor Conferences in September
Aug 26, 2025
Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?
Aug 21, 2025
Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA
Jul 15, 2025
Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate
Jul 8, 2025
Adagene announces up to $25 million strategic investment from Sanofi
Jul 1, 2025
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Jun 3, 2025

Reviews